| Literature DB >> 26869417 |
Liem Andhyk Halim1, Vera Brinks1, Wim Jiskoot2, Stefan Romeijn2, Rob Haselberg3, Chris Burns4, Meenu Wadhwa4, Huub Schellekens5.
Abstract
Comprehensive physicochemical characterization and biological assays are essential parts in assessing quality attributes of biologicals. Here, we compared the quality of different marketed recombinant human erythropoietin (epoetin) products: originators, Eprex and NeoRecormon as well as 2 biosimilars, Retacrit and Binocrit. In addition, assessment of batch-to-batch variability was included by collecting 2 or more batches of each product. Common assays which included sodium dodecyl sulfate-polyacrylamide gel electrophoresis, high-performance size-exclusion chromatography, asymmetrical flow field-flow fractionation, capillary zone electrophoresis, and potency testing were used. Of the tested products and among batches of single products, variations in epoetin content, isoform profiles, and potency were found. Ultimately, this study demonstrated the high quality of epoetin products with some degree of variation among products and batches, confirming the "similar but not identical" paradigm of biologicals.Entities:
Keywords: biosimilar; immunogenicity; physicochemical properties; protein characterization; recombinant human erythropoietin
Mesh:
Substances:
Year: 2016 PMID: 26869417 DOI: 10.1016/j.xphs.2015.10.019
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534